| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.018 | 0.7 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.7 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |